Needham Maintains Buy on Evolent Health, Raises Price Target to $6
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.
Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.